1st Quarter - Report — ARENTFOX SCHIFF LLP for ALLERGAN PLC (2015)

Firm

ARENTFOX SCHIFF LLP

Client

ALLERGAN PLC

Income

$70,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trans-Pacific Partnership (TPP) intellectual property protection and policy

Lobbyist	Covered position, as disclosed
PHILIP ENGLISH	—
ALEX MANNING New	Staff Dir., Cybersecurity, Infrastructure Protection, and Security Technologies Subcomm., House Homeland Security Comm.; Leg. Dir., Rep. Michael McCaul; Prof. Staff, House Gov't Reform Comm.; Leg. Corr., Leg. Asst., Leg. Dir., Rep. Thaddeus McCotter
MATTHEW MOSHER NOLAN New	—

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Copyright/Patent/Trademark CPT

H.R. 9 (Innovation Act), all provisions relating to fee shifting

Lobbyist	Covered position, as disclosed
AMY DEMSKE	—
PHILIP ENGLISH	—

Contacted: U.S. Trade Representative (USTR); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 9 (114th)

Health Issues HCR

Abuse deterrent formulations

Lobbyist	Covered position, as disclosed
PHILIP ENGLISH	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.